Literature DB >> 9834074

TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus.

O Hultgren1, H P Eugster, J D Sedgwick, H Körner, A Tarkowski.   

Abstract

To evaluate the importance of the proinflammatory cytokines TNF and lymphotoxin-alpha (LT alpha) in an experimental model of Staphylococcus aureus sepsis and arthritis, we used TNF/LT alpha-double-deficient mice raised on the C57BL/6 background. Mice were i.v. inoculated with a toxic shock syndrome toxin-1 (TSST-1)-producing S. aureus strain, LS-1. Intravenous inoculation of a high dose of bacteria (1 x 10(7)/mouse) resulted in 67% mortality in TNF/LT alpha-deficient mice, whereas none of the controls died (p = 0.009). Those results correlated to a significantly decreased phagocytosis in vitro and inefficient bacterial clearance in vivo in mice lacking capacity to produce TNF/LT alpha. Thus, at day 6 after inoculation, S. aureus could not be found in the bloodstream of controls, but bacteremia developed in all TNF/LT alpha-deficient mice examined (p = 0.02). Interestingly, upon infection with a lower dose of staphylococci (3 x 10(6)/mouse) the mortality was overall low, but the frequency of arthritis was clearly higher in the wild-type group as compared with the TNF/LT alpha-deficient mice (40% vs 13%). Histopathologic examination revealed a lower frequency of synovitis (38% vs 90%, p < 0.05) and erosivity (25% vs 60%, NS) in TNF/LT alpha-deficient mice as compared with wild-type counterparts. Our results show the importance of TNF/LT alpha in defense against systemic S. aureus infections and point out the detrimental role of these cytokines as mediators of inflammatory response in S. aureus arthritis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834074

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance.

Authors:  I Gjertsson; O H Hultgren; A Tarkowski
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

2.  Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica.

Authors:  Paul B Mann; Kelly D Elder; Mary J Kennett; Eric T Harvill
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

Review 3.  The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.

Authors:  Thomas Hehlgans; Klaus Pfeffer
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

4.  Staphylococcus aureus infection after splenectomy and splenic autotransplantation in BALB/c mice.

Authors:  F M Teixeira; B F Fernandes; A B Rezende; R R P Machado; C C S Alves; S M Perobelli; S I Nunes; R E Farias; M F Rodrigues; A P Ferreira; S C Oliveira; H C Teixeira
Journal:  Clin Exp Immunol       Date:  2008-09-08       Impact factor: 4.330

5.  Granulocyte-macrophage colony-stimulating factor in Staphylococcus aureus-induced arthritis.

Authors:  M Verdrengh; A Tarkowski
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  Dual neutralization of TNFR-2 and MMP-2 regulates the severity of S. aureus induced septic arthritis correlating alteration in the level of interferon gamma and interleukin-10 in terms of TNFR2 blocking.

Authors:  Sahin Sultana; Rajen Dey; Biswadev Bishayi
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

Review 7.  Tumor necrosis factor inhibitors and infection complications.

Authors:  Monica Crawford; Jeffrey R Curtis
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

8.  Septic arthritis in the native joint.

Authors:  Meghan B Brennan; Jennifer L Hsu
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

9.  Streptococcus pyogenes infection induces septic arthritis with increased production of the receptor activator of the NF-kappaB ligand.

Authors:  Atsuo Sakurai; Nobuo Okahashi; Ichiro Nakagawa; Shigetada Kawabata; Atsuo Amano; Takashi Ooshima; Shigeyuki Hamada
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Sulfatide attenuates experimental Staphylococcus aureus sepsis through a CD1d-dependent pathway.

Authors:  Jakub Kwiecinski; Sara Rhost; Linda Löfbom; Maria Blomqvist; Jan Eric Månsson; Susanna L Cardell; Tao Jin
Journal:  Infect Immun       Date:  2013-01-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.